The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN)(CNSX:VGW) (the “Company” or “Valens“) is pleased to announce the appointment of A.Tyler Robson, currently Chief Operating Officer and a Company director, as its new Chief Executive Officer (“CEO“) effective immediately. Rob van Santen, CEO of Valens GroWorks Corp., will remain engaged as Chief Financial Officer (“CFO“) of the Company, with Annie …
Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN)(CNSX:VGW) (the “Company” or “Valens“) is pleased to announce the appointment of A.Tyler Robson, currently Chief Operating Officer and a Company director, as its new Chief Executive Officer (“CEO“) effective immediately. Rob van Santen, CEO of Valens GroWorks Corp., will remain engaged as Chief Financial Officer (“CFO“) of the Company, with Annie Storey, the current CFO, continuing her engagement as Controller.
Rob van Santen commented: “With the Company’s transition from corporate acquisition vehicle to a scalable cannabis sector operator, the time for an industry-savvy leader and spokesperson to take the helm has come. Tyler’s unique skill set and operational knowledge have been key drivers for the expansion of our growing Canadian and U.S.-based commercial interests. Tyler’s robust relationship network and exceptional commercial marijuana cultivation record enhances our ability to engage in strategic transactions, and to attract both Licensed Producers (“LP’s”) and selected late-stage LP applicants seeking support and partnership alternatives”.
2017 Annual General Meeting
The Company will host its Annual General Meeting of shareholders on Friday, August 4, 2017 at 10:00 am PDT at the 14th Floor (entrance on the 15th floor), 1040 West Georgia Street, Vancouver, British Columbia, Canada V6E 4H1.
About Valens GroWorks Corp.
Valens GroWorks Corp is a CSE-listed company with an aggressive acquisition strategy in progress, financing the expansion of fully licensed operations in Arizona, the proposed buildout of late-stage LP applicant Royal Green Acres Manufacturing, as well as providing management, consulting, testing and support services to domestic and international licensees.
The Company has two wholly-owned subsidiaries based in the Okanagan Valley of British Columbia: 1) Valens Agritech Ltd. (“VAL“), a post-inspection applicant anticipating receipt of a Controlled Drugs and Substances Dealers Licence for the cultivation and processing of marijuana, and 2) Supra THC Services Inc. (“Supra“), a Health Canada Dealers-Licensed cannabis testing lab with an established scientific team supporting its operations, positioning to provide sector-leading analytical and proprietary services to Licensed Producers and ACMPR patients.
On behalf of the Board of Directors,
VALENS GROWORKS CORP.
Robert van Santen, Chief Financial Officer
Notice regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or is “anticipating”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include statements regarding the use of proceeds from a proposed funding. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability to obtain any necessary financing; the economy generally; competition; regulation and anticipated and unanticipated costs and delays. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek safe harbor.
Rob van Santen commented: “With the Company’s transition from corporate acquisition vehicle to a scalable cannabis sector operator, the time for an industry-savvy leader and spokesperson to take the helm has come. Tyler’s unique skill set and operational knowledge have been key drivers for the expansion of our growing Canadian and U.S.-based commercial interests. Tyler’s robust relationship network and exceptional commercial marijuana cultivation record enhances our ability to engage in strategic transactions, and to attract both Licensed Producers (“LP’s”) and selected late-stage LP applicants seeking support and partnership alternatives”.
2017 Annual General Meeting
The Company will host its Annual General Meeting of shareholders on Friday, August 4, 2017 at 10:00 am PDT at the 14th Floor (entrance on the 15th floor), 1040 West Georgia Street, Vancouver, British Columbia, Canada V6E 4H1.
About Valens GroWorks Corp.
Valens GroWorks Corp is a CSE-listed company with an aggressive acquisition strategy in progress, financing the expansion of fully licensed operations in Arizona, the proposed buildout of late-stage LP applicant Royal Green Acres Manufacturing, as well as providing management, consulting, testing and support services to domestic and international licensees.
The Company has two wholly-owned subsidiaries based in the Okanagan Valley of British Columbia: 1) Valens Agritech Ltd. (“VAL“), a post-inspection applicant anticipating receipt of a Controlled Drugs and Substances Dealers Licence for the cultivation and processing of marijuana, and 2) Supra THC Services Inc. (“Supra“), a Health Canada Dealers-Licensed cannabis testing lab with an established scientific team supporting its operations, positioning to provide sector-leading analytical and proprietary services to Licensed Producers and ACMPR patients.
On behalf of the Board of Directors,
VALENS GROWORKS CORP.
Robert van Santen, Chief Financial Officer
Notice regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or is “anticipating”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include statements regarding the use of proceeds from a proposed funding. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability to obtain any necessary financing; the economy generally; competition; regulation and anticipated and unanticipated costs and delays. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek safe harbor.
Source: www.marketwired.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.